NCI-H322[H322]人
具體成交價(jià)以合同協(xié)議為準(zhǔn)
- 公司名稱 上海富雨生物科技有限公司
- 品牌
- 型號
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2025/2/11 15:45:47
- 訪問次數(shù) 31
聯(lián)系方式：陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時(shí)請說明是化工儀器網(wǎng)上看到的信息，謝謝!
NCI-H322[H322] 人非小細(xì)胞肺癌細(xì)胞
Catalogue No.: C1277
Product Format: a T25 flask
Culture Properties：貼壁
Complete Growth Medium: 89%1640+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
| Item | Specifications |
| a T25 flask | 2X106 |
| Manual | 1 copy |
ipilimumab, nivolumab, PD-1 inhibitors, PD-L1 inhibitors, checkpoint inhibitors, anticancer
vaccines, TVEC, and adoptive cell therapy.The advances in cancer immunotherapy copk with several oadtacles, limiting its widespread use and benefits so far only to a small suadet of patients. One of the underlying challenges remains to be the lack of representative nonclinical
采購中心
化工儀器網(wǎng)